Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Becker

Showing results (1331-1340 of 1,462) with videos related to

Pageof 147
Sort By:
Biorxiv : the Preprint Server for Biology|April 1, 2024
Elucidation and Pharmacologic Targeting of Master Regulator Dependencies in Coexisting Diffuse Midline Glioma SubpopulationsEster Calvo Fernández, Lorenzo Tomassoni, Xu Zhang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 5, 2011
Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meetingJakub Tolar, Jennifer E Adair, Michael Antoniou, et al.
Blood Advances|January 17, 2025
TP53 mutations are associated with CD19- relapse and inferior outcomes after blinatumomab in adults with ALLIbrahim Aldoss, Shanpeng Li, Jianying Zhang, et al.
Cell Metabolism|December 25, 2018
Inhibition of Mevalonate Pathway Prevents Adipocyte Browning in Mice and Men by Affecting Protein PrenylationMiroslav Balaz, Anton S Becker, Lucia Balazova, et al.
American Journal of Hematology|March 7, 2023
High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusionsIbrahim Aldoss, Michelle Afkhami, Dongyun Yang, et al.
Haematologica|November 7, 2024
Venetoclax in combination with a pediatric-inspired regimen for the treatment of newly diagnosed adults with Philadelphia chromosome-negative acute lymphoblastic leukemiaIbrahim Aldoss, Jianying Zhang, Kathryn Shimamoto, et al.
Blood|October 19, 2022
An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AMLMohamed L Sorror, Ted A Gooley, Barry E Storer, et al.
Laryngo- Rhino- Otologie|September 23, 2022
L Klimek, U Förster-Ruhrmann, H Olze, et al.
Blood|August 5, 2021
Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemiaMohamed L Sorror, Barry E Storer, Amir T Fathi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2024
Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage AdenocarcinomaJun-Chieh J Tsay, Fares Darawshy, Chan Wang, et al.
Pageof 147

Showing results (1331-1340 of 1,462) with videos related to

Sort By:
Pageof 147
Biorxiv : the Preprint Server for Biology|April 1, 2024
Elucidation and Pharmacologic Targeting of Master Regulator Dependencies in Coexisting Diffuse Midline Glioma SubpopulationsEster Calvo Fernández, Lorenzo Tomassoni, Xu Zhang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 5, 2011
Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meetingJakub Tolar, Jennifer E Adair, Michael Antoniou, et al.
Blood Advances|January 17, 2025
TP53 mutations are associated with CD19- relapse and inferior outcomes after blinatumomab in adults with ALLIbrahim Aldoss, Shanpeng Li, Jianying Zhang, et al.
Cell Metabolism|December 25, 2018
Inhibition of Mevalonate Pathway Prevents Adipocyte Browning in Mice and Men by Affecting Protein PrenylationMiroslav Balaz, Anton S Becker, Lucia Balazova, et al.
American Journal of Hematology|March 7, 2023
High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusionsIbrahim Aldoss, Michelle Afkhami, Dongyun Yang, et al.
Haematologica|November 7, 2024
Venetoclax in combination with a pediatric-inspired regimen for the treatment of newly diagnosed adults with Philadelphia chromosome-negative acute lymphoblastic leukemiaIbrahim Aldoss, Jianying Zhang, Kathryn Shimamoto, et al.
Blood|October 19, 2022
An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AMLMohamed L Sorror, Ted A Gooley, Barry E Storer, et al.
Laryngo- Rhino- Otologie|September 23, 2022
L Klimek, U Förster-Ruhrmann, H Olze, et al.
Blood|August 5, 2021
Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemiaMohamed L Sorror, Barry E Storer, Amir T Fathi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2024
Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage AdenocarcinomaJun-Chieh J Tsay, Fares Darawshy, Chan Wang, et al.
Pageof 147